GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (FRA:7V3) » Definitions » Other Stockholders Equity

Cantargia AB (FRA:7V3) Other Stockholders Equity : €-0.00 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cantargia AB Other Stockholders Equity?

Cantargia AB's Other Stockholders Equity for the quarter that ended in Sep. 2024 was €-0.00 Mil.

Cantargia AB's quarterly Other Stockholders Equity increased from Mar. 2024 (€0.00 Mil) to Jun. 2024 (€0.00 Mil) but then declined from Jun. 2024 (€0.00 Mil) to Sep. 2024 (€-0.00 Mil).

Cantargia AB's annual Other Stockholders Equity declined from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€-0.00 Mil) but then increased from Dec. 2022 (€-0.00 Mil) to Dec. 2023 (€-0.00 Mil).


Cantargia AB Other Stockholders Equity Historical Data

The historical data trend for Cantargia AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantargia AB Other Stockholders Equity Chart

Cantargia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cantargia AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cantargia AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Cantargia AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cantargia AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantargia AB Business Description

Industry
Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.

Cantargia AB Headlines

No Headlines